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e under thebstract Background: Hemoglobinopathies represent a major public health prob-
lem in Saudi Arabia (SA). Reports suggest that their higher prevalence is not evenly
distributed in SA. Regional differences were studied in sickle cell disease and b-thal-
assemia and their at-risk marriages using national data.
Methods: The carrier and case status of sickle cell disease and b-thalassemia
were determined in couples approaching marriage between 2004 and 2009 using
standard blood tests. Prevalence of both diseases and at-risk marriages in different
SA administrative and geographical regions were calculated and compared.
Results: A total of 15,72,140 men and women were examined over 6 years. This
represented 0.06% of the entire population of Saudi Arabia. The prevalence of couples
who tested positive for sickle cell was 45.1 (42.4 for carriers and 2.7 for cases) per
1000 persons examined. The prevalence was highest in the Eastern region (134.1
per 1000), followed by Southern andWestern regions (55.6 and 28.5 per 1000, respec-
tively) and lowest in Central and Northern regions (13.7 and 13.5 per 1000, respec-
tively). The prevalence of couples testing positive for b-thalassemia was 18.5 (18.0
for carriers and 0.5 for cases) per 1000 persons examined. The prevalence was highest
in the Eastern region (59.0), moderate in the Southern, Western and Central regions
(14.2, 10.2, and 10.1 per 1000, respectively) and lowest in the Northern region (3.9).
Conclusion: Vast regional differences in hemoglobinopathies among adult Saudis
are being reported that may help policy makers better allocate resources of available
preventive programs.
ª 2011 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1
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62 Z.A. Memish et al.1. Introduction
Hemoglobinopathies are among the most com-
monly inherited genetic disorders in humans.
The World Health Organization (WHO) estimated
that at least 5% of the worlds population are
genetic carriers for hemoglobinopathies (2.9% for
thalassemia and 2.3% for sickle cell disease).
Sickle cell disease is found predominantly in
Africa and the Middle East, while b-thalassemia
is predominant in Asia, the Mediterranean basin,
and the Middle East [1]. Sickle cell disease and
b-thalassemia represent a major public health
problem in Saudi Arabia (SA) [2]. Both diseases
can be cured by bone marrow transplantation;
however, curative treatment is costly and unavail-
able except for a limited number of cases. As a
result, both diseases carry with them huge eco-
nomic and psychological burdens on the patient
and the society. As a consequence, premarital
screening and genetic counseling (PMS&GC) was
mandated in SA in 2004 [3]. The main program
objective was to reduce the prevalence of sickle
cell disease and b-thalassemia by reducing the
number of at-risk marriages. All couples with mar-
riage proposals have to be tested for both dis-
eases and get the appropriate counseling (if
required) before consummating their marriage.
The PMS&GC program was spread over five geo-
graphic regions (Central, Eastern, Western, North-
ern and Southern) and 13 administrative regions in
order to cover the entire country. The Saudi pop-
ulation was 22.7 million at the start of the pro-
gram in 2004 and it reached 25.4 million by
2009; the population covered by the PMS&GC pro-
gram was limited to those individuals seeking
marriage.
Prevalence studies published before [4–10]
and after [11–16] the PMS&GC program sug-
gested that the higher prevalence of sickle cell
disease and b-thalassemia are not evenly distrib-
uted in SA. With the exception of a few studies
[10,12,13], most studies covered only isolated
regions in SA. Comparing prevalence from the
majority of these studies is difficult because of
inconsistency of study design, differences in
laboratory techniques, diversity of the covered
population (neonatal, children, adults), variabil-
ity of studied years (pre- or post-PMS&GC pro-
gram), and differences in sample power. The
scope of this study is focused on regional differ-
ences in the prevalence of sickle cell disease and
thalassemia, as well as the frequency of at-risk
marriages using 6 years of national data from
the PMS&GC program.2. Methods
2.1. Population and geography
The PMS&GC program covered the entire Saudi pop-
ulation. Geographically, SA consists of 13 adminis-
trative regions, 20 Ministry of Health regions
(after subdividing some administrative regions), or
five geographic regions (Central, Eastern, Western,
Northern and Southern).
2.2. The Saudi PMS&GC program
The program was stipulated by law in December
2003 and implemented in February 2004. The pro-
gram infrastructure consisted of 150 health care
reception clinics, 70 laboratories, and 78 genetic
counseling clinics covering the 13 administrative
regions across the country. All couples tested be-
tween 2004 and 2009 were included in the analysis.
According to the program guidelines, couples
with marriage proposals had to report to the near-
est health care clinic to apply for premarital certif-
icates. At the health care clinics, the program staff
collected basic demographic information, took
blood samples (in EDTA anticoagulant), and offered
educational materials about the program to the
couples who applied. The blood samples were then
sent to the designated laboratory for testing for
sickle cell disease and thalassemia using hemoglo-
bin (Hb) electrophoresis. Other blood tests done in-
cluded: complete blood count, peripheral blood
film, reticulocyte count, and sickling test. The
diagnosis of b-thalassemia trait was established
when Hb A2 was above 3.5% with low MCV in ab-
sence of Iron deficiency anemia. The diagnosis of
alpha thalassemia was not included in the program
due to its low clinical significance in most of the
cases. In order to establish the diagnosis of sickle
cell trait, the test must show the presence of Hb
S with positive sickling. The results were inter-
preted according to standard laboratory diagnostic
protocols [11,17].
Test results were shared with the examined cou-
ples before issuing the premarital compatibility
certificates. The test results categorized each
member of the potential couple as: free (healthy),
carriers (carrying the trait) and cases (having the
disease) as regards the genetic make-up of sickle
cell disease and/or b-thalassemia. Safe marriages
were declared when both or at least one member
of the couple was healthy. At-risk marriages
were declared when both members of the couple
were carriers or cases (or one was a case and the
other was a carrier) of sickle cell disease and/or
Table 1 Number of examined persons in the PMS&GCa program between 2004 and 2009 and their genetic testing results by administrative and geographic regions of Saudi
Arabia.
Examined
persons
Genetic testing Sickle cell disease b-Thalassemia At-risk
marriages
Prevalence of
positives
per 1000
examined
persons
Prevalence of sickle cell
disease per 1000
examined persons
Positives Negatives Carriers Cases Total Carriers Cases Total Carriers Cases Total
Administrative regions:
Riyadh 315,589 10,483 305,106 5600 399 5999 4112 372 4484 390 33.2 17.7 1.3 19.0
Hail 47,038 106 46,932 93 9 102 4 0 4 3 2.3 2.0 0.2 2.2
Qassim 96,391 350 96,041 175 5 180 164 6 170 3 3.6 1.8 0.1 1.9
Eastern region 258,137 49,850 208,287 32,017 2604 34,621 15,094 135 15,229 5175 193.1 124.0 10.1 134.1
Baha 43,208 1968 41,240 1547 10 1557 385 26 411 76 45.5 35.8 0.2 36.0
Madinah 111,521 2691 108,830 2144 135 2279 375 37 412 97 24.1 19.2 1.2 20.4
Makkah 326,128 13,961 312,167 9634 248 9882 4050 29 4079 1055 42.8 29.5 0.8 30.3
Northern borders 21,802 285 21,517 70 5 75 171 39 210 4 13.1 3.2 0.2 3.4
Tabouk 48,897 1407 47,490 1114 139 1253 149 5 154 35 28.8 22.8 2.8 25.6
Jouf 35,066 151 34,915 95 7 102 48 1 49 1 4.3 2.7 0.2 2.9
Aseer 164,706 5335 159,371 4858 168 5026 303 6 309 388 32.4 29.5 1.0 30.5
Jazzan 74,793 12,956 61,837 8894 577 9471 3370 115 3485 1682 173.2 118.9 7.7 126.6
Najran 28,864 425 28,439 408 7 415 10 0 10 16 14.7 14.1 0.2 14.4
Total 15,72,140 99,968 14,72,172 66,649 4313 70,962 28,235 771 29,006 8925 63.6 42.4 2.7 45.1
P < 0.001 P < 0.001 P < 0.001 P < 0.001
Geographic regions:
Central 459,018 10,939 448,079 5868 413 6281 4280 378 4658 396 23.8 12.8 0.9 13.7
Eastern 258,137 49,850 208,287 32,017 2604 34,621 15,094 135 15,229 5175 193.1 124.0 10.1 134.1
Western 480,857 18,620 462,237 13,325 393 13,718 4810 92 4902 1228 38.7 27.7 0.8 28.5
Northern 105,765 1843 103,922 1279 151 1430 368 45 413 40 17.4 12.1 1.4 13.5
Southern 268,363 18,716 249,647 14,160 752 14,912 3683 121 3804 2086 69.7 52.8 2.8 55.6
Total 15,72,140 99,968 14,72,172 66,649 4313 70,962 28,235 771 29,006 8925 63.6 42.4 2.7 45.1
P < 0.001 P < 0.001 P < 0.001 P < 0.001
a PMS&GC, premarital screening and genetic counseling.
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64 Z.A. Memish et al.b-thalassemia. Couples with safe marriage test re-
sults were issued instant compatibility certificates
while at-risk couples were asked to attend personal
genetic counseling meetings before issuing incom-
patibility certificates.2.3. Data analysis
It was the health care clinics responsibility
(N = 150) to collect and manage their own local lab-
oratory data. Each of the 20 health regions were
required to collect data from their respective
health care clinics and fax standard monthly re-
ports to the Directorate General of Non-Communi-
cable Diseases of the Ministry of Health in Riyadh.
The aggregate data collected from the reports
were used to construct a central database that
was used for the current analysis. The prevalence
of carriers and cases of sickle cell disease and/or
b-thalassemia were expressed per 1000 examined
persons. The frequency of at-risk marriages was ex-
pressed per 1000 examined persons and per 100 po-
sitive results. Carrier–case ratio was defined as the
ratio of carriers to cases among those who had any
positive results for sickle cell disease and/or thal-
assemia. Prevalence of both diseases and at-risk
marriages in different SA administrative and geo-
graphical regions were calculated and compared.
Significant regional differences in prevalence and
ratios were tested using Chi Square. All P-values
were two-tailed. P-value <0.05 was considered as
significant. OpenEpi (version 2.2, Atlanta, GA,
USA) and Microsoft Office excel (2003) were used
for all statistical analyses.134.1
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Figure 1 Prevalence of sickle cell disease and b-thalassem
persons in the PMS&GC program between 2004 and 2009 by3. Results
A total of 15,72,140 men and women examined be-
tween 2004 and 2009 were included and analyzed.
The average number of men and women examined
in the PMS&GC program was 262,000 annually (ran-
ged between 242,000 in 2004 and 296,000 in 2009).
This represented an annual frequency of 10.9 mar-
riage proposals per 1000 Saudis.
Out of 15,72,140 men and women examined,
70,962 (4.5%) tested positive for sickle cell gene
(66,649 carriers and 4313 cases) (Table 1). The prev-
alence of the sickle cell gene was 45.1 (42.4 for car-
riers and 2.7 for cases) per 1000 examined persons.
The prevalence was highest in the Eastern region
(134.1), followed by Southern and Western regions
(55.6 and 28.5, respectively) and lowest in Central
and Northern regions (13.7 and 13.5, respectively)
(Fig. 1). The highest prevalence of the sickle cell
gene per 1000 examined persons in SA was seen in
two administrative regions (Fig. 2A): the Eastern
region (134.1) and Jazzan (126.6). However, four
administrative regions (Qassim, Hail, Jouf, and
Northern borders) demonstrated the lowest preva-
lence of sickle cell disease at below 5 per 1000
examined persons. The remaining administrative re-
gions demonstrated the sickle cell disease preva-
lence between 14.4 and 36.0 per 1000 examined
persons. There were considerable variations in the
sickle cell disease prevalence within the same
administrative or geographic regions. For example,
sickle cell disease prevalence in Qunfudah (135.7)
was significantly higher than its administrative (Mak-
kah: 30.3) or geographic (Western: 28.5) regions. On
the other hand, the sickle cell disease prevalence in13.7 13.510.2 10.1
3.92.6 0.9 0.4
stern Central Northern
Sickle cell disease
β-thalassemia
At-risk marriages
ia and frequency of at-risk marriages among examined
geographic regions of Saudi Arabia.
Marked regional variations in the prevalence of sickle cell disease 65Hafr Albaten (4.4) was significantly lower than other
health regions of the Eastern region (Ahsa:, 183.4;
Eastern region including Dammam: 128.2; overall:
134.1). The overall carrier–case ratio for sickle cell
disease was 15.5 with considerable regional varia-
tions being highest in the Western region (33.9)
and lowest in the Northern region (8.5) (Fig. 2).
Out of 15,72,140 men and women examined,
29,006 (1.8%) tested positive (28,535 carriers and
771 cases) for b-thalassemia gene (Table 1). The
prevalence of b-thalassemia was 18.5 (18.0 for car-
riers and 0.5 for cases) per 1000 examined persons.
The prevalence was highest in the Eastern region
(59.0), moderate in the Southern, Western and Cen-
tral regions (14.2, 10.2, and 10.1, respectively),
and lowest in the Northern region (3.9), (Fig. 1).Figure 2 Annual prevalence of total sickle cell disease (
persons in the PMS&GC program between 2004 and 2009 bySimilar to sickle cell disease, Eastern region and
Jazzan were the two administrative regions with
the highest prevalence of b-thalassemia (59.0 and
46.6, respectively) (Fig. 2B). Four administrative
regions (Riyadh, Makkah, Northern borders, and
Albaha) had moderate b-thalassemia prevalence
(range between 9.5 and 14.2). The remaining
administrative regions demonstrated low b-thalas-
semia prevalence (below 4 per 1000 examined per-
sons). Similar to sickle cell disease, there were
considerable variations in the prevalence of b-thal-
assemia within the same administrative or geo-
graphical regions. For example, Qunfudah was
significantly higher than other health regions of
the Western region while Hafr Albaten, which
administratively belongs to the Eastern region,A, above) and thalassemia (B, below) among examined
administrative regions of Saudi Arabia.
66 Z.A. Memish et al.demonstrated zero prevalence of b-thalassemia.
The overall carrier–case ratio for b-thalassemia
was 36.6 with considerable regional variations
being highest in the Eastern region (111.8) and low-
est in the Northern region (8.2), (Fig. 3).
3.1. At-risk marriages
In this category, a total of 8925 at-risk marriages
were cited because both members of the couple
were carriers or cases (or one was a case and the
other was a carrier) of sickle cell disease and/or
b-thalassemia. The frequency of at-risk marriages
was 5.7 per 1000 examined persons and 8.9 per
100 positive results. Similar to the prevalence of
sickle cell disease and b-thalassemia, the fre-
quency of at-risk marriages was highest in the East-
ern region followed by the Southern and Western
regions and lowest in the Northern and Central re-
gions (Fig. 1).
4. Discussion
This report studied regional differences in hemo-
globinopathies and at-risk marriages using 6 years
of national data from the PMS&GC program.
Detecting regional differences in hemoglobinopa-
thies may be critical for policy makers to better
allocate resources and sometimes modify services
to achieve the highest efficiency of the available
screening program. Although this study is not the
first to address regional differences in sickle cell
disease and b-thalassemia in SA [10,12,13], it bet-
ter reflects the current situation because the data
from the PMS&GC program is unified, standardized
and involves the whole country.12.3
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Figure 3 Carrier–case ratio of sickle cell disease and b
program between 2004 and 2009 by geographic regions of SaWhen comparing the current overall prevalence
of sickle cell disease to previously published stud-
ies, the demonstrated rates seems to be much low-
er than studies done before the PMS&GC program,
but are similar to those done after the PMS&GC
program. In the largest national study of males
and females between the ages of 2 and 60 years
old in the 1980s and the early 1990s, El-Hazmi
et al. [18] estimated sickle cell disease carriers
and cases at 73.6 and 10.6 per 1000, respectively,
compared with 42.4 and 2.7, respectively in this
study which could be partially explained by the ab-
sence of the pediatric population in this study. In a
more recent study of patients aged between new-
born and 19 years old, Al-Qurashi et al. [13] esti-
mated sickle cell disease cases at 2.4 per 1000,
which is close to the estimation of this study. The
same findings were reported during the first 2 years
of PMS&GC program [12]. The differences in sickle
cell disease rates in this study and pre-PMS&GC
program studies may be confounded by the differ-
ences in the studied population and study methods.
Moreover, adult-based rates (as in this study)
should be lower than rates calculated from neo-
nates or children as the former rates reflect inci-
dence while the later rates reflect incidence and
survival.
Unlike sickle cell disease, regional and overall
prevalence of b-thalassemia in the current study
was much lower than previously published rates
irrespective of the timing of the PMS&GC program,
with probably wider difference after the program
than before it. For example, between the 1980s
and the 1990s, b-thalassemia rates were estimated
at 130 and 36 per 1000 examined persons in Eastern
and Central regions (compared to 58.5 and 9.3),.9
14.2
8.5
52.3
11.3 8.2
stern Central Northern
Sickle cell disease 
β-thalassemia
-thalassemia among examined persons in the PMS&GC
udi Arabia.
Marked regional variations in the prevalence of sickle cell disease 67respectively [10]. b-Thalassemia carriers per 1000
were estimated earlier from the PMS&GC program
to be 32 in all regions of SA and 34 in Al-Hassa re-
gion (compared with 18 and 26, respectively) [12].
The current regional differences in sickle cell
disease and b-thalassemia in SA were generally sim-
ilar to those reported previously, but the magnitude
of such differences was probably lower. Similar to
previous studies [10,12,13,18,19], the highest prev-
alence for both diseases was seen in the Eastern re-
gion while the lowest prevalence was seen in the
Northern region (b-thalassemia) or both the North-
ern and Central regions (sickle cell disease). For
sickle cell disease, geographic regional differences
were 10-fold in the current study compared with
about 25-fold in previous studies [10,13]. For b-
thalassemia, the Eastern-Riyadh difference was
6.7-fold in the current study compared with about
9.0-fold in previous studies [12]. In both sickle cell
disease and b-thalassemia prevalence, Jazzan was
comparable with the Eastern region, but higher
than the rest of the Southern and Western adminis-
trative regions (such difference was higher with b-
thalassemia than with sickle cell disease). This cre-
ated a Central belt of low prevalence of sickle cell
disease sandwiched between high Eastern and
South-Western regions. Such distinction was not
seen with b-thalassemia (Fig. 2A and B).
It is difficult to explain regional differences in
sickle cell disease and b-thalassemia in SA. Certain
cultural factors in SA may contribute to the high
prevalence of both diseases. These include the high
frequency of consanguineous marriages (exceeding
55%) and the large family size [20–22]. Regional
variations in the consanguinity rates in SA were re-
ported with conflicting results [20,21]. Some pub-
lished data suggested that the prevalence of first
degree consanguinity is highest in the Eastern re-
gion (40.9%) and lowest in the Northern region
(17.9%) [21]. It was also suggested that malaria hy-
per-endemic areas provide survival advantage and
hence higher prevalence of sickle cell trait
[18,19]. According to this hypothesis, areas that
used to be endemic with malaria in the past (coast-
al areas in the Eastern and Southwestern regions)
concentrated the sickle cell gene. Areas with high-
er prevalence of hemoglobinopathies (e.g. the
Eastern region) could make it relatively difficult
for an at-risk couple member to find an alternative
socially suitable safe-match compared with low
prevalence areas creating a vicious cycle of sickle
cell trait concentration.
It was suggested that the Eastern region has
more benign sickle cell disease compared with
the South-West [23–25]. This possibly offered bet-
ter survival chances of cases in the Eastern region.Consequently, the carrier–case ratio of sickle cell
disease in this study was lower in the Eastern re-
gion (12.3) than the Western (33.9) and Southern
(18.8) regions. Unlike the sickle cell disease, the
carrier–case ratio of b-thalassemia was highest in
the Eastern (111.3) and Western (52.3) regions.
Whether this indicates more aggressive b-thalasse-
mia in these regions compared with Central and
Northern regions is something to be investigated.
Not surprisingly, the Eastern region that had the
highest prevalence of both sickle cell disease and
b-thalassemia embraced 58% of all detected at-risk
marriages during the study. This may necessitate
allocation of more resources (clinics, laboratories
and counselors) to the Eastern region. In addition,
studying regional differences of responsible muta-
tions, cultural factors, and morbidity and mortality
behavior of both diseases may help the policy mak-
ers to improve the available prevention and man-
agement programs.
5. Conclusion
Based on 6 years of national data from the PMS&GC
program, this study reports the vast regional differ-
ences in hemoglobinopathies among adult Saudi
nationals approaching marriage. This may help pol-
icy-makers better allocate resources of available
preventive and management programs.
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